Madison Muller Robert Langreth Bloomberg
-
Business
Lilly wins FDA approval for new drug to slow Alzheimer’s
Eli Lilly & Co.’s Alzheimer’s treatment was cleared in the US as the second drug to slow progression of the…
Read More »
Eli Lilly & Co.’s Alzheimer’s treatment was cleared in the US as the second drug to slow progression of the…
Read More »